As of 2026-04-16, the Intrinsic Value of Initiator Pharma A/S (INIT.ST) is -1.24 SEK. This INIT.ST valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.37 SEK, the upside of Initiator Pharma A/S is -136.80%.
Based on its market price of 3.37 SEK and our intrinsic valuation, Initiator Pharma A/S (INIT.ST) is overvalued by 136.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.24 - -1.24 | -1.24 | -136.80% |
| P/E | (1.55) - (2.12) | (1.98) | -158.9% |
| DDM - Stable | (3.67) - (33.44) | (18.56) | -650.6% |
| DDM - Multi | (3.85) - (27.54) | (6.78) | -301.1% |
| Market Cap (mil) | 230.68 |
| Beta | 0.85 |
| Outstanding shares (mil) | 68.45 |
| Enterprise Value (mil) | 195.46 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.70% |
| Cost of Debt | 5.00% |
| WACC | 6.66% |